Literature DB >> 15113676

2beta,3beta-Difluorosialic acid derivatives structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.

Kiyoshi Ikeda1, Satoru Kitani, Kazuki Sato, Takashi Suzuki, Chika Hosokawa, Yasuo Suzuki, Kiyoshi Tanaka, Masayuki Sato.   

Abstract

A series of 4-O-substituted 2beta,3beta-difluorosialic acid derivatives (3a-d) has been synthesized. A key intermediate was synthesized efficiently by the electrophilic syn-addition of fluorine to the double bond of a glycal precursor using molecular fluorine or xenon difluoride in the presence of BF(3).OEt(2). Among compounds 3a-d, the 4-O-thiocarbamoylmethyl derivative 3c showed the most potent inhibitory activity against sialidase of human parainfluenza virus type 1. [structure: see text].

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113676     DOI: 10.1016/j.carres.2004.02.029

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.

Authors:  Christopher J Vavricka; Yue Liu; Hiromasa Kiyota; Nongluk Sriwilaijaroen; Jianxun Qi; Kosuke Tanaka; Yan Wu; Qing Li; Yan Li; Jinghua Yan; Yasuo Suzuki; George F Gao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.

Authors:  Tanguy Eveno; Larissa Dirr; Ibrahim M El-Deeb; Patrice Guillon; Mark von Itzstein
Journal:  Viruses       Date:  2019-05-05       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.